Stable Chronic Obstructive Pulmonary Disease (COPD) Management Under a Tiered Medical System in China

References

• GOLD. Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease 2021 report [2020-11-01]. Available from: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf. Accessed December 31, 2021
   Google Scholar
• Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-9
   PubMed Web of Science ®Google Scholar
• National Health Commission of the People’s Republic of China. Statistical bulletin on the development of China’s health undertakings in 2019 [2020-06-06]. Available from: http://www.nhc.gov.cn/guihuaxxs/s10748/202006/ebfe31f24cc145b198dd730603ec4442.shtml.Accessed December 31, 2021.
   Google Scholar
• Zheng J. A nationwide questionnaire survey on clinical application of pulmonary function testing in China. Chinese J Tuberculosis Respir Dis. 2002;25:69–73.
   Google Scholar
• Fang LW, Bao HL, Wang BH, et al. Survey and analyses of rate of spirometry examination in adults aged 40 years and older in China, 2014. Chinese J Epidemiol. 2018;39:593–599. doi:10.3760/cma.j.issn.0254-6450.2018.05.010
   Google Scholar
• Gao Y, Zheng J, Liang J, Wu Q. Overview of standardized training programme for clinical application and quality control of pulmonary function testing in China. Chin J Pract Internal Medic. 2019;39:746–750.
   Google Scholar
• Skloot GS, Edwards NT, Enright PL. Four-year calibration stability of the EasyOne portable spirometer. Respir Care. 2010;55:873–877.
   PubMed Web of Science ®Google Scholar
• Bambra G, Jalota L, Kapoor C, et al. Office spirometry correlates with laboratory spirometry in patients with symptomatic asthma and COPD. Clin Respir J. 2017;11:805–811. doi:10.1111/crj.12419
   PubMed Web of Science ®Google Scholar
• Zhou L, Jiang Y, Du C, et al. Development of an internet-of-things based portable spirometer and the validation of its accuracy. Int J Respir. 2019;02:113–118.
   Google Scholar
• Gerbase MW, Dupuis-Lozeron E, Schindler C, et al. Agreement between spirometers: a challenge in the follow-up of patients and populations? Respiration. 2013;85(6):505–514. doi:10.1159/000346649
   PubMed Web of Science ®Google Scholar
• Gea J, Agusti A, Roca J. Pathophysiology of muscle dysfunction in COPD. J Appl Physiol (1985). 2013;114:1222–1234. doi:10.1152/japplphysiol.00981.2012
   PubMed Web of Science ®Google Scholar
• Elliott MW, Mulvey DA, Moxham J, Green M, Branthwaite MA. Domiciliary nocturnal nasal intermittent positive pressure ventilation in COPD: mechanisms underlying changes in arterial blood gas tensions. Eur Respir J. 1991;4:1044–1052.
   PubMed Web of Science ®Google Scholar
• Meecham JD, Paul EA, Jones PW, Wedzicha JA. Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am J Respir Crit Care Med. 1995;152(2):538–544. doi:10.1164/ajrccm.152.2.7633704
   PubMed Web of Science ®Google Scholar
• Duiverman ML. Noninvasive ventilation in stable hypercapnic COPD: what is the evidence? ERJ Open Research. 2018;4:00012–2018. doi:10.1183/23120541.00012-2018
   PubMedGoogle Scholar
• Hoiland RL, Mladinov S, Barak OF, et al. Oxygen therapy improves cerebral oxygen delivery and neurovascular function in hypoxaemic chronic obstructive pulmonary disease patients. Exp Physiol. 2018;103:1170–1177. doi:10.1113/EP086994
   PubMed Web of Science ®Google Scholar
• Wilson ME, Dobler CC, Morrow AS, et al. Association of home noninvasive positive pressure ventilation with clinical outcomes in chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA. 2020;323:455–465. doi:10.1001/jama.2019.22343
   PubMed Web of Science ®Google Scholar
• Murphy PB, Rehal S, Arbane G, et al. Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation: a randomized clinical trial. JAMA. 2017;317:2177–2186. doi:10.1001/jama.2017.4451
   PubMed Web of Science ®Google Scholar
• Liu Y, Fu Q, Dai B, Zhang J. Efficacy of home noninvasive positive pressure ventilation on patients with severe stable chronic obstructive pulmonary disease in China: a meta-analysis. Chin J Respir Crit Care Med. 2019;18:209–216.
   Google Scholar
• Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J. 2005;26:1138–1180. doi:10.1183/09031936.05.00055705
   PubMed Web of Science ®Google Scholar
• ECDC. Seasonal influenza vaccination and antiviral use in EU/EEA Member States [2018-12-18]. Available from: https://www.ecdc.europa.eu/en/publications-data/seasonal-influenza-vaccination-antiviral-use-eu-eea-member-states. Accessed December 31, 2021.
   Google Scholar
• CDC. Flu vaccination coverage, United States, 2019–20 influenza season [2020-10-01]. Available from: https://www.cdc.gov/flu/fluvaxview/coverage-1920estimates.htm. Accessed December 31, 2021.
   Google Scholar
• CDC. Vaccination coverage among adults in the United States, national health interview survey, 2017 [2018-02-08]. Available from: https://www.cdc.gov/vaccines/imz-managers/coverage/adultvaxview/pubs-resources/NHIS-2017.html. Accessed December 31, 2021.
   Google Scholar
• Wang Y, Cheng M, Wang S, et al. Vaccination coverage with the pneumococcal and influenza vaccine among persons with chronic diseases in Shanghai, China, 2017. BMC Public Health. 2020;20:359. doi:10.1186/s12889-020-8388-3
   PubMed Web of Science ®Google Scholar
• Fan J, Cong S, Wang N, et al. Pneumococcal vaccination rate in chronic obstructive pulmonary disease patients aged 40 years or older in China, 2014-2015. Chinese J Epidemiol. 2020;41:1028–1033. doi:10.3760/cma.j.cn112338-20200124-00056
   Google Scholar
• Petite SE. Role of long-acting muscarinic antagonist/long-acting β 2-agonist therapy in chronic obstructive pulmonary disease. Ann Pharmacother. 2017;51(8):696–705. doi:10.1177/1060028017705149
   PubMed Web of Science ®Google Scholar
• Horita N, Goto A, Shibata Y, et al. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev. 2017;2(3):CD012066. doi:10.1152/ajplegacy.1975.229.3.754
   PubMed Web of Science ®Google Scholar
• Roche N, Chapman KR, Vogelmeier CF, et al. Blood eosinophils and response to maintenance chronic obstructive pulmonary disease treatment. Data from the FLAME Trial Am J Respir Crit Care Med. 2017;195:1189–1197. doi:10.1164/rccm.201701-0193OC
   PubMed Web of Science ®Google Scholar
• Pascoe S, Barnes N, Brusselle G, et al. Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial. Lancet Respir Med. 2019;7:745–756. doi:10.1016/S2213-2600(19)30190-0
   PubMed Web of Science ®Google Scholar
• Suissa S, Dell’Aniello S, Ernst P. Comparative effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: cohort study in real-World Clinical Practice. Chest. 2020;157:846–855. doi:10.1016/j.chest.2019.11.007
   PubMed Web of Science ®Google Scholar
• Liou JT, Lin CW, Tsai CL, et al. Risk of severe cardiovascular events from add-on Tiotropium in chronic obstructive pulmonary disease. Mayo Clin Proc. 2018;93:1462–1473. doi:10.1016/j.mayocp.2018.05.030
   PubMed Web of Science ®Google Scholar
• Zacarias EC, Castro AA, Cendon S. Effect of theophylline associated with short-acting or long-acting inhaled beta2-agonists in patients with stable chronic obstructive pulmonary disease: a systematic review. J Bras Pneumol. 2007;33:152–160. doi:10.1590/S1806-37132007000200009
   PubMedGoogle Scholar
• Devereux G, Cotton S, Barnes P, et al. Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial. Trials. 2015;16:267. doi:10.1186/s13063-015-0782-2
   PubMed Web of Science ®Google Scholar
• Devereux G, Cotton S, Fielding S, et al. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT. Health Technol Assess. 2019;23:1–146. doi:10.3310/hta23370
   PubMed Web of Science ®Google Scholar